176 related articles for article (PubMed ID: 18272323)
21. Stability of set-shifting and planning abilities in patients with schizophrenia.
Tyson PJ; Laws KR; Roberts KH; Mortimer AM
Psychiatry Res; 2004 Dec; 129(3):229-39. PubMed ID: 15661316
[TBL] [Abstract][Full Text] [Related]
22. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic drug treatment, clinical characteristics and cognitive processing speed in patients with schizophrenia: results from the ELAN study.
Frasch K; Weiser P; Becker T; Längle G; Steinert T; Niederreiner C; Pfiffner C; Jäger S; Bayer W; Eschweiler GW; Kilian R
Pharmacopsychiatry; 2012 Jun; 45(4):138-45. PubMed ID: 22174026
[TBL] [Abstract][Full Text] [Related]
24. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.
Kertzman S; Reznik I; Grinspan H; Weizman A; Kotler M
Isr J Psychiatry Relat Sci; 2008; 45(2):114-20. PubMed ID: 18982837
[TBL] [Abstract][Full Text] [Related]
26. Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions.
Gaebel W; Riesbeck M; Janssen B; Schneider F; Held T; Mecklenburg H; Sass H
Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):175-84. PubMed ID: 12910348
[TBL] [Abstract][Full Text] [Related]
27. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
Kelemen O; Kiss I; Benedek G; Kéri S
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
[TBL] [Abstract][Full Text] [Related]
28. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
29. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
Sharma T
Br J Psychiatry Suppl; 1999; (38):44-51. PubMed ID: 10884899
[No Abstract] [Full Text] [Related]
30. Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes.
Eberhard J; Riley F; Levander S
Eur Arch Psychiatry Clin Neurosci; 2003 Apr; 253(2):84-8. PubMed ID: 12799746
[TBL] [Abstract][Full Text] [Related]
31. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
32. Computer-aided neurocognitive remediation as an enhancing strategy for schizophrenia rehabilitation.
Cavallaro R; Anselmetti S; Poletti S; Bechi M; Ermoli E; Cocchi F; Stratta P; Vita A; Rossi A; Smeraldi E
Psychiatry Res; 2009 Oct; 169(3):191-6. PubMed ID: 19740550
[TBL] [Abstract][Full Text] [Related]
33. A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia.
Albus M; Hubmann W; Scherer J; Dreikorn B; Hecht S; Sobizack N; Mohr F
Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):262-7. PubMed ID: 12563534
[TBL] [Abstract][Full Text] [Related]
34. The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.
Selva-Vera G; Balanzá-Martínez V; Salazar-Fraile J; Sánchez-Moreno J; Martinez-Aran A; Correa P; Vieta E; Tabarés-Seisdedos R
BMC Psychiatry; 2010 Jun; 10():47. PubMed ID: 20550658
[TBL] [Abstract][Full Text] [Related]
35. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
36. Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia.
Ogino S; Miyamoto S; Tenjin T; Kitajima R; Ojima K; Miyake N; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Tatsunami S; Kubota H; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):78-83. PubMed ID: 20828595
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
[TBL] [Abstract][Full Text] [Related]
39. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
[TBL] [Abstract][Full Text] [Related]
40. Effects of quetiapine on cognitive functions in schizophrenic patients: a preliminary single-trial ERP analysis.
Zhang Y; Lehmann M; Shobeiry A; Höfer D; Johannes S; Emrich HM; Dietrich DE
Pharmacopsychiatry; 2009 Jul; 42(4):129-34. PubMed ID: 19585390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
